Article
Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa.
Advances in experimental medicine and biology - 1 Jan 2022
Ortega Joseph T, Jastrzebska Beata
Abstract excerpt
Retinitis pigmentosa (RP) is a group of hereditary degenerative diseases affecting 1 of 4000 people worldwide and being the most prevalent cause of visual handicap among working populations in developed countries. These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR), rhodopsin reflected in the dysregulated membrane trafficking, stability and phototransduction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
